Ketosis-prone atypical diabetes: Glucagon is there, too

Diabetes Care

Volumn 36, Issue 1, 2013, Pages 8-10

  Lefèbvre, Pierre ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

GHRELIN; GLUCAGON; SOMATOSTATIN;

DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE PREDISPOSITION; GLUCOSE INTOLERANCE; HUMAN; HUMAN VERSUS ANIMAL COMPARISON; HYPERGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; INSULIN RESPONSE; INSULIN SENSITIVITY; KETOSIS PRONE ATYPICAL DIABETES; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NOTE; PANCREAS ISLET; PANCREAS ISLET ALPHA CELL; PANCREAS ISLET BETA CELL; REMISSION;

DIABETES MELLITUS, TYPE 1; DIABETIC KETOACIDOSIS; FEMALE; GLUCAGON-SECRETING CELLS; HUMANS; INSULIN-SECRETING CELLS; MALE;

EID: 84872044767     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc12-1696     Document Type: Note

References (16)

1. Zimmet P, Cowie C, Ekoe J-M, Shaw JE. Classification of diabetes and other categories of glucose intolerance. International Textbook of Diabetes Mellitus. DeFronzo RA, Ferrannini E, Keen H, Zimmet P, Eds. Chichester, John Wiley and Sons, 2004, p. 3-14
2. Ahrén B, Corrigan CB. Intermittent need for insulin in a subgroup of diabetic patients in Tanzania. Diabet Med 1985;2:262-264 (Pubitemid 15246125)
3. Balasubramanyam A, Nalini R, Hampe CS, Maldonado M. Syndromes of ketosis-prone diabetes mellitus. Endocr Rev 2008;29:292-302 (Pubitemid 351679700)
4. Mauvais-Jarvis F, Sobngwi E, Porcher R, et al. Ketosis-prone type 2 diabetes in patients of sub-Saharan African origin: clinical pathophysiology and natural history of beta-cell dysfunction and insulin resistance. Diabetes 2004;53:645-653 (Pubitemid 38270633)
5. Choukem SP, Sobngwi E, Fetita LS, et al. Multitissue insulin resistance despite nearnormoglycemic remission in Africans with ketosis-prone diabetes. Diabetes Care 2008;31:2332-2337
6. Sobngwi E, Choukem SP, Agbalika F, et al. Ketosis-prone type 2 diabetes mellitus and human herpes virus 8 infection in sub-Saharan Africans. JAMA 2008;299:2770-2776 (Pubitemid 351846852)
7. Choukem S-P, Sobngwi E, Boudou P, et al. β- and α-cell dysfunctions in Africans with ketosis-prone atypical diabetes during near-normoglycemic remission. Diabetes Care 2013;36:118-123
8. Umpierrez GE, Casals MM, Gebhart SP, Mixon PS, Clark WS, Phillips LS. Diabetic ketoacidosis in obese African-Americans. Diabetes 1995;44:790-795
9. Unger RH, Orci L. Paracrinology of islets and the paracrinopathy of diabetes. Proc Natl Acad Sci USA 2010;107:16009-16012
10. Lefèbvre P. Diabetes as a paracrinopathy of the islets of Langerhans. European Endocrinology 2011;7:79-82
11. Unger RH, Cherrington AD. Glucagonocentric restructuring of diabetes: a pathophysiologic and therapeutic makeover. J Clin Invest 2012;122:4-12
12. Unger RH. The Banting Memorial Lecture 1975. Diabetes and the alpha cell. Diabetes 1976;25:136-151
13. Lefèbvre PJ, Luyckx AS. Glucagon and diabetes: a reappraisal. Diabetologia 1979;16:347-354 (Pubitemid 9201997)
14. Bonner-Weir S, Orci L. New perspectives on the microvasculature of the islets of Langerhans in the rat. Diabetes 1982;31:883-889 (Pubitemid 12013792)
15. Meier JJ, Kjems LL, Veldhuis JD, Lefèbvre P, Butler PC. Postprandial suppression of glucagon secretion depends upon intact insulin pulsatile secretion: further evidence for the intra-islet insulin hypothesis. Diabetes 2006;55:1051-1056 (Pubitemid 44100181)
16. Bosco D, Armanet M, Morel P, et al. Unique arrangement of α- and β-cells in human islets of Langerhans. Diabetes 2010;59:1202-1210